Clinically relevant mutations in mycobacterial LepA cause rifampicin-specific phenotypic resistance.
Ontology highlight
ABSTRACT: Although all wild-type bacterial populations exhibit antibiotic tolerance, bacterial mutants with higher or lower tolerant subpopulation sizes have been described. We recently showed that in mycobacteria, phenotypically-resistant subpopulations can grow in bulk-lethal concentrations of rifampicin, a first-line anti-tuberculous antibiotic targeting RNA polymerase. Phenotypic resistance was partly mediated by paradoxical upregulation of RNA polymerase in response to rifampicin. However, naturally occurring mutations that increase tolerance via this mechanism had not been previously described. Here, we used transposon insertional mutagenesis and deep sequencing (Tnseq) to investigate rifampicin-specific phenotypic resistance using two different in vitro models of rifampicin tolerance in Mycob
SUBMITTER: Wang BW
PROVIDER: S-EPMC7242378 | biostudies-literature | 2020 May
REPOSITORIES: biostudies-literature
ACCESS DATA